semaglutide cardiovascular trial news outcomes today 2025 Oral Reduces Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized SELECT Trial – SELECT Cardiovascular Trial Information |

GLP-1 receptor agonist for weight loss and fertility: social media and online perception versus evidence-based medicine

It is the first triple-hormone-receptor agonist to reach advanced clinical trials, activating three distinct metabolic pathways that individually would each justify their own drug development program

Pentadeca-Arginate is also being studied for its role in healthy aging because of how well it supports energy, brain health, and circulationwithout overstimulating the body

Using animal models, the researchers found that GLP-1 drugs improve blood flow to the heart after a heart attack by activating potassium channels, which relax pericytes

Holm, M

Nr man vurderer en udbyder, er brugeroplevelsen i fokus: indlsningstider, intuitive menuer og tydelige knapper til ind- og udbetaling betyder meget i hverdagen